Cargando...

Low Expression of ARHI Is Associated with Shorter Progression-Free Survival in Pancreatic Endocrine Tumors

Little is known about the molecular anomalies involved in the development and progression of malignancy of pancreatic endocrine tumors (PETs). A recently identified member of the Ras family, Ras homologue member I (ARHI), has been shown to be involved in breast, ovary, and thyroid carcinogenesis. Un...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Irene, Dalai, Edoardo, Missiaglia, Stefano, Barbi, Giovanni, Butturini, Claudio, Doglioni, Massimo, Falconi, Aldo, Scarpa
Formato: Artigo
Idioma:Inglês
Publicado: Neoplasia Press Inc. 2007
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1838575/
https://ncbi.nlm.nih.gov/pubmed/17401457
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!